Schizophrenia Research
Volume 76, Issue 2 , Pages 159-171 , 15 July 2005

Unchanged packing density but altered size of neurofilament immunoreactive neurons in the prefrontal cortex in schizophrenia and major depression

  • Jose Javier Miguel-Hidalgo

      Affiliations

    • Department of Psychiatry, University of Mississippi Medical Center, 2500 North State Street, P.O. Box 127, Jackson, MS 39216, United States
    • Corresponding Author InformationCorresponding author. Department of Psychiatry and Human Behavior, University of Mississippi Medical Center, 2500 North State Street, P.O. Box 127, Jackson, MS 39216-4505, United States. Tel.: +1 601 984 5791; fax: +1 601 984 5899.
    • ,
  • Priti Dubey

      Affiliations

    • Department of Psychiatry, University of Mississippi Medical Center, 2500 North State Street, P.O. Box 127, Jackson, MS 39216, United States
    • ,
  • Qingmei Shao

      Affiliations

    • Department of Psychiatry, University of Mississippi Medical Center, 2500 North State Street, P.O. Box 127, Jackson, MS 39216, United States
    • ,
  • Craig Stockmeier

      Affiliations

    • Department of Psychiatry, University of Mississippi Medical Center, 2500 North State Street, P.O. Box 127, Jackson, MS 39216, United States
    • Department of Psychiatry, Case Western Reserve University, Cleveland, OH 44106, United States
    • ,
  • Grazyna Rajkowska

      Affiliations

    • Department of Psychiatry, University of Mississippi Medical Center, 2500 North State Street, P.O. Box 127, Jackson, MS 39216, United States

Received 30 July 2004 ,Revised 21 February 2005 ,Accepted 21 February 2005.

References 

  1. Ackerley S, Thornhill P, Grierson AJ, Brownlees J, Anderton BH, Leigh PN, et al. Neurofilament heavy chain side arm phosphorylation regulates axonal transport of neurofilaments. J. Cell Biol. 2003;161:489–495
  2. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. 4th ed.. Washington, D.C.: American Psychiatric Association; 1995;
  3. Barbas H. Connections underlying the synthesis of cognition, memory, and emotion in primate prefrontal cortices. Brain Res. Bull. 2000;52:319–330
  4. Barbas H, Rempel-Clower N. Cortical structure predicts the pattern of corticocortical connections. Cereb. Cortex. 1997;7:635–646
  5. Baxter LR, Schwartz JM, Phelps ME, Mazziotta JC, Guze BM, Selin CE, et al. Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch. Gen. Psychiatry. 1989;46:243–250
  6. Beasley C, Cotter D, Khan N, Pollard C, Sheppard P, Varndell I, et al. Glycogen synthase kinase-3beta immunoreactivity is reduced in the prefrontal cortex in schizophrenia. Neurosci. Lett. 2001;302:117–120
  7. Buchsbaum MS, Someya T, Ying Teng C, Abel L, Chin S, Najafi A, et al. PET and MRI of the thalamus in never-medicated patients with schizophrenia. Am. J. Psychiatry. 1996;153:191–199
  8. Byne W, Buchsbaum MS, Mattiace LA, Hazlett EA, Kemether E, Elhakem SL, et al. Postmortem assessment of thalamic nuclear volumes in subjects with schizophrenia. Am. J. Psychiatry. 2002;159:59–65
  9. Carmichael ST, Price JL. Limbic connections of the orbital and medial prefrontal cortex in macaque monkeys. J. Comp. Neurol. 1995;363:615–641
  10. Cavada C, Company T, Tejedor J, Cruz-Rizzolo RJ, Reinoso-Suarez F. The anatomical connections of the macaque monkey orbitofrontal cortex. A review. Cereb. Cortex. 2000;10:220–242
  11. Chakos MH, Lieberman JA, Alvir J, Bilder R, Ashtari M. Caudate nuclei volumes in schizophrenic patients treated with typical antipsychotics or clozapine. Lancet. 1995;345:456–457
  12. Cotter D, Mackay D, Landau S, Kerwin R, Everall I. Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. Arch. Gen. Psychiatry. 2001;58:545–553
  13. Cullen TJ, Walker MA, Parkinson N, Craven R, Crow TJ, Esiri MM, et al. A postmortem study of the mediodorsal nucleus of the thalamus in schizophrenia. Schizophr. Res. 2003;60:157–166
  14. Drevets WC. Neuroimaging studies of mood disorders: implications for a neural model of major depression. Biol. Psychiatry. 2000;48:813–829
  15. Erbas B, Bekdik C, Erbengi G, Enunlu T, Aytac S, Kumbasar H, et al. Regional cerebral blood flow changes in chronic alcoholism using Tc-99m HMPAO SPECT. Comparison with CT parameters. Clin. Nucl. Med. 1992;17:123–127
  16. Franke FE, Schachenmayr W, Osborn M, Altmannsberger M. Unexpected immunoreactivities of intermediate filament antibodies in human brain and brain tumors. Am. J. Pathol. 1991;139:67–79
  17. Frazier JA, Giedd JN, Kaysen D, Albus K, Hamburger S, Alaghband_Rad J, et al. Childhood-onset schizophrenia: brain MRI rescan after 2 years of clozapine maintenance treatment. Am. J. Psychiatry. 1996;153:564–566
  18. Goodwin G. Neuropsychological and neuroimaging evidence for the involvement of the frontal lobes in depression. J. Psychopharmacol. (Oxf.). 1997;11:115–122
  19. Guidato S, Tsai LH, Woodgett J, Miller CC. Differential cellular phosphorylation of neurofilament heavy side-arms by glycogen synthase kinase-3 and cyclin-dependent kinase-5. J. Neurochem. 1996;66:1698–1706
  20. Gundersen HJ. The nucleator. J. Microsc. 1988;151(Pt. 1):3–21
  21. Gundersen HJ, Jensen EB. The efficiency of systematic sampling in stereology and its prediction. J. Microsc. 1987;147:229–263
  22. Gundersen HJ, Bagger P, Bendtsen TF, Evans SM, Korbo L, Marcussen N, et al. The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. APMIS. 1988;96:857–881
  23. Henn FA, Braus DF. Structural neuroimaging in schizophrenia. An integrative view of neuromorphology. Eur. Arch. Psychiatry Clin. Neurosci. 1999;249(Suppl 4):48–56
  24. Hof PR. Morphology and neurochemical characteristics of the vulnerable neurons in brain aging and Alzheimer's disease. Eur. Neurol. 1997;37:71–81
  25. Hof PR, Morrison JH. Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: II. Primary and secondary visual cortex. J. Comp. Neurol. 1990;301:55–64
  26. Hof PR, Cox K, Morrison JH. Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: I. Superior frontal and inferior temporal cortex. J. Comp. Neurol. 1990;301:44–54
  27. Hof PR, Mufson EJ, Morrison JH. Human orbitofrontal cortex: cytoarchitecture and quantitative immunohistochemical parcellation. J. Comp. Neurol. 1995;359:48–68
  28. Hof PR, Ungerleider LG, Webster MJ, Gattass R, Adams MM, Sailstad CA, et al. Neurofilament protein is differentially distributed in subpopulations of corticocortical projection neurons in the macaque monkey visual pathways. J. Comp. Neurol. 1996;376:112–127
  29. Hof PR, Glezer II, Nimchinsky EA, Erwin JM. Neurochemical and cellular specializations in the mammalian neocortex reflect phylogenetic relationships: evidence from primates, cetaceans, and artiodactyls. Brain Behav. Evol. 2000;55:300–310
  30. Jung C, Shea TB. Neurofilament subunits undergo more rapid translocation within retinas than in optic axons. Mol. Brain Res. 2004;122:188–192
  31. Kato T, Shioiri T, Murashita J, Hamakawa H, Takahashi Y, Inubushi T, et al. Lateralized abnormality of high energy phosphate metabolism in the frontal lobes of patients with bipolar disorder detected by phase-encoded 31P-MRS. Psychol. Med. 1995;25:557–566
  32. Kennedy S, Javanmard M, Vaccarino F. A review of functional neuroimaging in mood disorders: positron emission tomography and depression. Can. J. Psychiatry. 1997;42:467–475
  33. Kozlovsky N, Belmaker RH, Agam G. Low GSK-3 activity in frontal cortex of schizophrenic patients. Schizophr. Res. 2001;52:101–105
  34. Kritzer MF, Goldman-Rakic PS. Intrinsic circuit organization of the major layers and sublayers of the dorsolateral prefrontal cortex in the rhesus monkey. J. Comp. Neurol. 1995;359:131–143
  35. Law AJ, Harrison PJ. The distribution and morphology of prefrontal cortex pyramidal neurons identified using anti-neurofilament antibodies SMI32, N200 and FNP7. Normative data and a comparison in subjects with schizophrenia, bipolar disorder or major depression. J. Psychiatr. Res. 2003;37:487–499
  36. Lee H, Tarazi FI, Chakos M, Wu H, Redmond M, Alvir JM, et al. Effects of chronic treatment with typical and atypical antipsychotic drugs on the rat striatum. Life Sci. 1999;64:1595–1602
  37. Lim KO, Hedehus M, Moseley M, de Crespigny A, Sullivan EV, Pfefferbaum A. Compromised white matter tract integrity in schizophrenia inferred from diffusion tensor imaging. Arch. Gen. Psychiatry. 1999;56:367–374
  38. Manoach DS, Gollub RL, Benson ES, Searl MM, Goff DC, Halpern E, et al. Schizophrenic subjects show aberrant fMRI activation of dorsolateral prefrontal cortex and basal ganglia during working memory performance. Biol. Psychiatry. 2000;48:99–109
  39. McCarley RW, Wible CG, Frumin M, Hirayasu Y, Levitt JJ, Fisher IA, et al. MRI anatomy of schizophrenia. Biol. Psychiatry. 1999;45:1099–1119
  40. Miguel-Hidalgo JJ, Rajkowska G. Immunohistochemistry of neural markers for the study of the laminar cytoarchitecture in celloidin sections from the human cerebral cortex. J. Neurosci. Methods. 1999;93:69–79
  41. Nimchinsky EA, Hof PR, Young WG, Morrison JH. Neurochemical, morphologic, and laminar characterization of cortical projection neurons in the cingulate motor areas of the macaque monkey. J. Comp. Neurol. 1996;374:136–160
  42. Pakkenberg B. Pronounced reduction of total neuron number in mediodorsal thalamic nucleus and nucleus accumbens in schizophrenics. Arch. Gen. Psychiatry. 1990;47:1023–1028
  43. Pant HC, Veeranna . Neurofilament phosphorylation. Biochem. Cell. Biol. 1995;73:575–592
  44. Passero S, Nardini M, Battistini N. Regional cerebral blood flow changes following chronic administration of antidepressant drugs. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 1995;19:627–636
  45. Pierri JN, Volk CL, Auh S, Sampson A, Lewis DA. Decreased somal size of deep layer 3 pyramidal neurons in the prefrontal cortex of subjects with schizophrenia. Arch. Gen. Psychiatry. 2001;58:466–473
  46. Pierri JN, Volk CL, Auh S, Sampson A, Lewis DA. Somal size of prefrontal cortical pyramidal neurons in schizophrenia. Differential effects across neuronal subpopulations. Biol. Psychiatry. 2003;54:111–120
  47. Popken GJ, Bunney WE, Potkin SG, Jones EG. Subnucleus-specific loss of neurons in medial thalamus of schizophrenics. Proc. Natl. Acad. Sci. U. S. A. 2000;97:9276–9280
  48. Rajkowska G, Goldman-Rakic PS. Cytoarchitectonic definition of prefrontal areas in the normal human cortex: I. Quantitative criteria for distinguishing areas 9 and 46. Cereb. Cortex. 1995;4:307–322
  49. Rajkowska G, Goldman-Rakic PS. Cytoarchitectonic definition of prefrontal areas in the normal human cortex: II. Variability in locations of areas 9 and 46. Cereb. Cortex. 1995;4:323–337
  50. Rajkowska G, Selemon LD. Cellular pathology in the dorsolateral prefrontal cortex distinguishes schizophrenia from bipolar disorder. Curr. Mol. Med. 2003;3:427–436
  51. Rajkowska G, Selemon LD, Goldman-Rakic PS. Reduction in neuronal sizes in prefrontal cortex of schizophrenics and Huntington patients. Schizophr. Res. 1995;15:31
  52. Rajkowska G, Selemon LD, Goldman-Rakic PS. Neuronal and glial somal size in the prefrontal cortex: a postmortem morphometric study of schizophrenia and Huntington disease. Arch. Gen. Psychiatry. 1998;55:215–224
  53. Rajkowska G, Miguel-Hidalgo JJ, Wei J, Dilley G, Pittman SD, Meltzer HY, et al. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol. Psychiatry. 1999;45:1085–1098
  54. Rajkowska G, Halaris A, Selemon L. Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder. Biol. Psychiatry. 2001;49:741–752
  55. Rajkowska G, Miguel-Hidalgo JJ, Makkos Z, Meltzer H, Overholser J, Stockmeier C. Layer-specific reductions in GFAP-reactive astroglia in the dorsolateral prefrontal cortex in schizophrenia. Schizophr. Res. 2002;57:127–138
  56. Scheepers FE, de_Wied CC, Pol HE, van de Flier W, van der Linden JA, Kahn RS. The effect of clozapine on caudate nucleus volume in schizophrenic patients previously treated with typical antipsychotics. Neuropsychopharmacology. 2001;24:47–54
  57. Selemon LD, Rajkowska G, Goldman-Rakic PS. Abnormally high neuronal density in the schizophrenic cortex: a morphometric analysis of prefrontal area 9 and occipital area 17. Arch. Gen. Psychiatry. 1995;52:805–818
  58. Selemon L, Rajkowska G, Goldman-Rakic P. Elevated neuronal density in prefrontal area 46 in brains from schizophrenic patients: application of a 3-Dimensional, stereologic counting method. J. Comp. Neurol. 1998;392:402–412
  59. Shaw G, Osborn M, Weber K. Reactivity of a panel of neurofilament antibodies on phosphorylated and dephosphorylated neurofilaments. Eur. J. Cell Biol. 1986;42:1–9
  60. Steffens D, Krishnan K. Structural neuroimaging and mood disorders: recent findings, implications for classification, and future directions. Biol. Psychiatry. 1998;43:705–712
  61. Sweeney JA, Strojwas MH, Mann JJ, Thase ME. Prefrontal and cerebellar abnormalities in major depression: evidence from oculomotor studies. Biol. Psychiatry. 1998;43:584–594
  62. Zaidel DW, Esiri MM, Harrison PJ. Size, shape, and orientation of neurons in the left and right hippocampus: investigation of normal asymmetries and alterations in schizophrenia. Am. J. Psychiatry. 1997;154:812–818

PII: S0920-9964(05)00081-2

doi: 10.1016/j.schres.2005.02.015

Schizophrenia Research
Volume 76, Issue 2 , Pages 159-171 , 15 July 2005

Article Tools

* Image Usage & Resolution